Stimulation of resistance to 6-hydroxydopamine in a human neuroblastoma cell line by nerve growth factor

Neuroscience Letters
|October 23, 1981
PubMed

Insights

Nerve growth factor (NGF) treatment enhances the resistance of human neuroblastoma SY5Y cells to the neurotoxin 6-hydroxydopamine (6-OHDA). This NGF-induced protection also extends to hydrogen peroxide, suggesting a broad protective mechanism against oxidative stress.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Toxicology

Background:

  • Human neuroblastoma cell line SK-N-SH-SY5Y (SY5Y) exhibits characteristics of immature sympathetic neurons.
  • These cells are susceptible to the neurotoxin 6-hydroxydopamine (6-OHDA).
  • Understanding resistance mechanisms is crucial for neuroprotection research.

Purpose of the Study:

  • To investigate the effect of nerve growth factor (NGF) on the resistance of SY5Y cells to 6-OHDA.
  • To determine if NGF-induced resistance is specific to 6-OHDA or extends to related toxic agents.

Main Methods:

  • Culturing SY5Y cells with NGF to induce resistance.
  • Exposing NGF-treated cells to 6-OHDA and hydrogen peroxide (H2O2).
  • Assessing cell viability and resistance levels post-treatment.

Main Results:

  • Culturing SY5Y cells with NGF significantly increased their resistance to 6-OHDA.
  • This protection was maintained even after NGF withdrawal or colcemid treatment.
  • NGF-treated cells also demonstrated resistance to H2O2, a byproduct of 6-OHDA autoxidation.
  • Dibutyryl cyclic AMP did not confer resistance to 6-OHDA.

Conclusions:

  • Nerve growth factor (NGF) effectively confers resistance to 6-hydroxydopamine (6-OHDA) in SY5Y neuroblastoma cells.
  • NGF-mediated protection appears to involve mechanisms that also counteract oxidative stress, as evidenced by resistance to H2O2.
  • These findings highlight NGF as a potential agent for neuroprotection against specific toxins and oxidative damage.

Related Concept Videos